Unable to Verify Report of Advisers’ Appointment for $5 Billion Sale of Icon Cancer Care
Key Facts
It could not be verified that EQT appointed Goldman Sachs and Barrenjoey Capital Partners as advisers to sell Icon Cancer Care or that the potential deal is valued at $5 billion. The information came from a report published by the Australian Financial Review on November 12, 2026, but the report’s page was unavailable for verification. It therefore cannot be confirmed that a sale process has begun or that a valuation of this size is under consideration. EQT’s available statement also does not establish the value of its 2021 acquisition of Icon, leaving no documented basis for comparing a previous purchase price with the reported valuation. Goldman Sachs’ share closing data on November 10 are not directly relevant to verifying the sale report.
Icon’s published data on its Australian operations offer a picture of the group’s scale there. The company says it operates more than 30 centres, and that more than 50% of its treatment centres serve patients in outer suburbs and regional areas. This footprint reflects a presence extending beyond major cities to communities across Australia. Icon also says it invested more than A$250 million to establish its national network of cancer-care facilities. The network includes medical and radiation oncology centres, as well as comprehensive centres offering multiple services under one roof.
At group level, the Australian Trade and Investment Commission, Austrade, reported on September 9, 2026, that Icon operated 60 cancer centres and had about 4,000 employees. The commission added that the group handled nearly 4 million patient interactions a year. These figures show the scale of Icon’s operations, but do not establish a sale price or the existence of negotiations. Austrade also recorded the group’s presence in Southeast Asia, with 8 centres in Singapore, 3 in Malaysia and one in Indonesia. These locations place Icon’s operations within a broader regional footprint beyond its Australian network.
A previous sale of Icon involved a transaction valued at more than A$1 billion, according to law firm King & Wood Mallesons, which said it represented the shareholders. The consortium that bought the group included QIC, Goldman Sachs Private Equity and Pagoda. That value relates to the earlier transaction and does not, by itself, provide a basis for direct comparison with the reported $5 billion figure in the unavailable report. EQT’s statement also confirmed its agreement to acquire Icon in 2021, but did not disclose the deal’s value. The value of the previous acquisition and any potential current valuation therefore remain unverified in the available information.